Understanding your treatment: Folfox-6 +/- Avastin chemotherapy

Understanding your treatment: Folfiri +/- Avastin therapyПодробнее

The Rationale for FOLFOX and Bevacizumab in mCRCПодробнее

GI chemotherapy education - FolfoxПодробнее

FOLFOX and Avastin for metastatic colon cancerПодробнее

mCRC: Considerations for Localized Therapy and MaintenanceПодробнее

Dr. Cremolini on FOLFOXIRI Plus Bevacizumab For Metastatic Colorectal CancerПодробнее

FOxTROT: neoadjuvant FOLFOX chemotherapy in colorectal cancerПодробнее

Postoperative Chemotherapy for Advanced Rectal CancerПодробнее

TRIBE-2: FOLFOX or FOLFIRI With Bevacizumab in mCRCПодробнее

Dr. Herzog on the Optimal Use of Bevacizumab in Patients With Ovarian CancerПодробнее

Side Effects of Targeted Agents in Colorectal CancerПодробнее

Dr. Cathy Eng on Bevacizumab Plus FOLFOXIRI for Patients With mCRCПодробнее

FDA Revokes Avastin for Breast Cancer UseПодробнее

Second Line and Later Therapies - Metastatic Colorectal CancerПодробнее

Anti-VEGF Therapies for Advanced Colon CancerПодробнее

Howard Hochster, MD, discusses the optimal duration of FOLFOX therapy in stage III colon cancerПодробнее

Breast cancer drug AvastinПодробнее

Charles Fuchs, MD: Experience With Patients on Bevacizumab Plus ChemotherapyПодробнее

Bevacizumab and FOLFOX for stage III colon cancerПодробнее